Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06257017
What this trial is testing

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Yung NA 20
Large-scale testing (Phase 3)WithdrawnNCT07313891
What this trial is testing

Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) CancerUrothelial Carcinoma Bladder+1 more
Relmada Therapeutics, Inc.
Not applicableLooking for participantsNCT07728474
What this trial is testing

LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
LifeBiotic Medical Research Ltd. 60
Not applicableStudy completedNCT05223491
What this trial is testing

En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jørgen Bjerggaard Jensen 220
Testing effectiveness (Phase 2)Looking for participantsNCT06417190
What this trial is testing

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Who this might be right for
Muscle-Invasive Bladder CarcinomaTumor
Leslie Ballas 20
Not applicableStudy completedNCT07630909
What this trial is testing

Mesotherapy for the Management of Myofascial Pain Syndrome

Who this might be right for
Myofascial Pain Syndrome (MPS)
Future University in Egypt 22
Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Early research (Phase 1)Study completedNCT02316171
What this trial is testing

CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)

Who this might be right for
Non-muscle Invasive Bladder Cancer
Viralytics 16
Large-scale testing (Phase 3)Looking for participantsNCT06696794
What this trial is testing

Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shaogang Wang 180
Not applicableStudy completedNCT05822518
What this trial is testing

Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy

Who this might be right for
Cancer, BladderCystostomy; Complications
Menoufia University 42
Testing effectiveness (Phase 2)Looking for participantsNCT07019220
What this trial is testing

Chemoablation for Low-Grade Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Ekaterina Laukhtina 47
Not applicableStudy completedNCT05028660
What this trial is testing

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Elypta 43
Large-scale testing (Phase 3)Ended earlyNCT03224182
What this trial is testing

Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 118
Not applicableNot Yet RecruitingNCT07529639
What this trial is testing

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Who this might be right for
Urothelial Bladder CarcinomaBladder CarcinomaNon-Muscle-Invasive Bladder Cancer (NMIBC)+1 more
Assiut University 100
Not applicableUnknownNCT03739177
What this trial is testing

Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients

Who this might be right for
Bladder Cancer
Animated Dynamics, Inc. 150
Large-scale testing (Phase 3)WithdrawnNCT07342517
What this trial is testing

NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04690699
What this trial is testing

LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors

Who this might be right for
Solid TumorBladder CancerNon-muscle-invasive Bladder Cancer
Istari Oncology, Inc. 4
Not applicableStudy completedNCT02506504
What this trial is testing

Prevention of Post-exercise Muscle Fatigue and Effect on Exercise Training in Severe Patients With COPD.

Who this might be right for
Obstructive Lung Diseases
Centre Hospitalier Universitaire de Saint Etienne 22
Not applicableStudy completedNCT02252549
What this trial is testing

An International Randomized Study to Compare SPIES Versus WLI

Who this might be right for
Bladder Cancer
Clinical Research Office of the Endourological Society 700
Testing effectiveness (Phase 2)WithdrawnNCT03150836
What this trial is testing

Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Terence Friedlander, MD
Next Page